Scientific Advisory Boards
Alacrita is often engaged by clients to assist with scientific advisory boards. From within our consulting group, we have access to highly-credentialed industry leaders. We can also take on a lead role in planning and coordination. From our partners and extending consulting team, we have experts available for ad boards covering pre-clinical translational medicine through to late-phase development. This includes regarded Key Opinion Leaders (KOLs) from within clinical settings as well as academia.
Although we have scientific expertise covering a range of therapeutic areas, we have particular specialization in immuno-oncology, oncology, hematology, fibroses, inflammatory diseases, GI and pulmonary, along with particular experience in cell and gene therapies.
Whether your organization is seeking an in-depth review of existing assets, assets under consideration for in-licensing, prepping for Phase 3 or for a read out, we can assist you with the process.
We also offer ongoing post-advisory board support.